4F-MDMB-BINACA

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
4F-MDMB-BINACA
4F-MDMB-BINACA molecular structure.png
Identifiers
PubChem CID
ChemSpider
Chemical and physical data
FormulaC19H26FN3O3
Molar mass363.426
3D model (JSmol)

4F-MDMB-BINACA (also known as 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family.[1] It has been used as an active ingredient in synthetic cannabis products and sold as a designer drug. 4F-MDMB-BINACA is an agonist of the CB1 receptor, though it is unclear whether it is selective for this target.[2] In December 2019, the UNODC announced scheduling recommendations placing 4F-MDMB-BINACA into Schedule II.[3]

See also[edit]

References[edit]

  1. ^ "4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework". doi:10.1111/1556-4029.14101. Cite journal requires |journal= (help)
  2. ^ "4F-MDMB-BINACA(4F-MDMB-BUTINACA)" (PDF).
  3. ^ "December 2019 – WHO: World Health Organization recommends 12 NPS for scheduling".